PRGO FY 2021 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.1B+1.2% YoY

Gross Profit

$1.4B34.2% margin

Operating Income

$410M9.9% margin

Net Income

-$69M-1.7% margin

EPS (Diluted)

$-0.98

Cash Flow

Operating Cash Flow

$156M

Free Cash Flow

$4M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$10.4B

Total Liabilities

$5.3B

Stockholders' Equity

$5.2B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.1B	$4.1B	+1.2%
Gross Profit	$1.4B	$1.5B	-5.3%
Operating Income	$410M	$265M	+54.8%
Net Income	-$69M	-$163M	+57.6%